drugset / Trial / NCT01238783
Safety and Efficacy of AL-15469A 0.5% / AL-6515 0.3% Ophthalmic Suspension for Treatment of Bacterial Conjunctivitis
RandomizedParallel-groupDouble-blindTreatment
Summary
To assess safety and efficacy of AL-15469A 0.5% /AL-6515 0.3% Ophthalmic Suspension for treatment of bacterial conjunctivitis
Timeline
- Start
- 2011-01
- Primary completion
- 2011-12
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Moxifloxacin | Small molecule | 0.5 % | Topical |
| Subject | Nepafenac | Other / unclassified | 0.3 % | Topical |